Fri. Sep 20th, 2019

Global Digital Therapeutics Market is Expected to Grow at a GAGR of 21.1% Over the Next Eight Years, Owing to Increasing Adoption of Digital Therapeutics to Manage Chronic Lifestyle Diseases and Behavioral Disorders in North America Region, Says Absolute Markets Insights

Center for Managing Chronic Disease, University of Michigan has predicted that by 2020, 81 million Americans will have multiple chronic diseases such as of diabetes, asthma, anxiety, blood pressure and mental disorders. Digital therapeutics has become an important alternative for patients in this region to manage these conditions effectively. Growing digital therapeutics market has brought together regulators, engineers, healthcare practitioners and insurance providers in the healthcare system. Early adoption of these platforms in North America has transformed the healthcare industry and is predicted to grow in the future as well. Digital therapeutic programs are accomplishing this by enabling continuous monitoring of patient vitals and encourage adoption of healthy lifestyle behavior.

Furthermore, healthcare companies are also seeing great potential to pair digital therapeutics with traditional medicinal therapies. Along with this in 2016, U.S. Department of Health and Human Services announced that it will reimburse digital therapeutics programs offered by companies such as Omada Health, Canary Health, and Blue Mesa Health for administering the Diabetes Prevention Program. Non- Profit organizations such as Digital Therapeutics Alliance is playing a great role in advocating for digital therapeutics program in U.S. and across the globe. Food and Drug Administration’s seal of approval in 2017 for marketing digital platforms was one of the important development towards the acceptance and growth of digital therapeutics market in North America.

Request a Sample Copy of This Report@ https://www.absolutemarketsinsights.com/request_sample.php?id=199

Digital therapeutics are also used in conjunction with behavioral interventions. Web-based cognitive therapy programs coupled with digital dashboards, allow both patients and providers to track the health indicators closely and also monitor the game based interventions. Unlike most wellness devices that are directly sold to consumers. Digital therapeutics follow R&D path that is quite similar to drug development. Thus, the tools are duly evaluated in clinical studies and prescribed by a medical provider. Companies engaged in producing digital therapeutics are seeking regulatory approval, aiding the growth of global digital therapeutics market.

 “Digital Therapeutics – A balancing Act in North America? Digital therapeutics is drastically changing the landscape of healthcare industry in North America. As this field of medicine facilitates direct delivery of personalized treatment interventions it has taken up an additional responsibility to reduce the economic burden of the region.”

The detailed research study provides qualitative and quantitative analysis of the global digital therapeutics market. The market has been analyzed from demand as well as supply side. The geographical analysis done emphasizes on each of the major countries across North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

Some of the major players operating in the global digital therapeutics market are BLUE MESA HEALTH, CANARY HEALTH, Chrono Therapeutics Inc., Adherium, BigHealth, Diabetes Digital Media Ltd, Digital Therapeutics, Inc., Dthera Sciences, MANGO HEALTH, Merck & Co., Inc., Firstbeat, GINGER.IO, Glooko, Inc., Limbix , Livongo Health, Noom, Inc., Novartis AG, Omada Health, Inc., Proteus Digital Health, WellDoc, Inc.,Propeller Health among others.

Inquiry Before Buying This Report@ https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=199

By Products

  • Software
  • Devices

By Application

  • Cardiovascular Diseases
  • Central Nervous System (CNS) Disease
  • Diabetes
  • Gastrointestinal Disorders (GID)
  • Mental Health
  • Neurology
  • Obesity
  • Ophthalmology
  • Respiratory Diseases
  • Smoking Cessation
  • Others

By Distribution Channel

  • Business to Business
  • Business to Customer

By End User

  • Patients
  • Healthcare Providers
  • Payers
  • Employers
  • Other (Fitness and Wellness Centers, Gym, Etc.)

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Nordic Countries
      • Denmark
      • Finland
      • Iceland
      • Sweden
      • Norway
    • Benelux Union
      • Belgium
      • The Netherlands
      • Luxembourg
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
      • Indonesia
      • Thailand
      • Malaysia
      • Singapore
      • Rest of Southeast Asia
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Kuwait
    • South Africa
    • Rest of Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America

Contact Us:
Company: Absolute Markets Insights
Contact Name: Shreyas Tanna
Phone: +91-740-024-2424
Email id: sales@absolutemarketsinsights.com
Website: https://www.absolutemarketsinsights.com/